AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 82 min read$TLRY

Tilray Brands posts record Q1 revenue $257.1M and gross profit $77.5M; adjusted EBITDA reaffirmed

Tilray Brands reported Q1 2027 revenue of $257.1M, up 23% YoY, and gross profit of $77.5M with a 30% margin. The company had a net loss of $40.0M but reaffirmed adjusted EBITDA guidance of $68M-$75M. Beverage and international segments showed growth, while cannabis margins improved.

Original reporting
tradingview.com
Published Oct 8, 2026, 11:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 11:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Tilray Brands posts record Q1 revenue $257.1M and gross profit $77.5M; adjusted EBITDA reaffirmed — source image
Source · tradingview.com
Decision brief

The 30-second read

$TLRYNeutralMed
01

Why it matters

Earnings beat revenue expectations, margins improved, but loss persists; guidance unchanged.

02

Market read

Tilray's earnings may lift sentiment in the cannabis sector and influence peer valuations.

03

What to watch

Integration of BrewDog acquisition and debt repayment effects are not fully reflected in the earnings.

Relevance 9/10Novelty 9/10Timing: today

Background

Tilray Brands reported Q1 FY2027 record revenue of $257.1M, gross profit $77.5M, net loss $40M, and reaffirmed FY2027 adjusted EBITDA guidance of $68-75M.

Company-level read

Ticker impact

$TLRYNeutralMedium confidence
Context

Tilray Brands reported record Q1 FY2027 revenue of $257.1M and reaffirmed FY2027 adjusted EBITDA guidance of $68-75M.

Expected impact

likely modest upside as investors price in revenue growth and stable guidance

Evidence & confidence

Revenue growth and improved margins suggest operational progress, but ongoing loss limits bullishness.

Market effects

Sector

Positive earnings could boost broader cannabis sector sentiment.

Regional

North American cannabis market may see increased investor interest.

Global

International investors may view Tilray's expansion as a sign of sector maturation.

Counterpoint

What could challenge this read

Continued net loss and debt reduction may indicate underlying cost pressures despite revenue growth.

Key entities

  • company
    Tilray Brands

    Cannabis producer

Read at source← All news

Also covered by

3 outlets

Related articles

OCT 8
$TLRYMed

Tilray Brands (TLRY) Shares Slip Premarket After Q1 Revenue Miss

Tilray Brands (TLRY) reported Q1 revenue of $257.2M, up 23% YoY but below estimates by $9.7M. Cannabis revenue declined 13%, while beverage and distribution segments grew. The company posted a net loss of $3.0M but beat adjusted EPS estimates by $0.16. Tilray's P/S ratio is 0.45, below historical and industry averages, reflecting market skepticism about future growth.

gurufocus.com3 min
OCT 8
$TLRYMed

Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit…

Tilray Brands, Inc. (TLRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution First-Quarter Results

SEC EDGAR 8-K2 min
AUG 24
$CURLFHighAI 9/10

Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.

Curaleaf has made an unsolicited bid for Aurora Cannabis, offering a 45% premium. Aurora has not accepted the deal. Tilray Brands and Canopy Growth are also engaging in consolidation. Aurora recently acquired Safari Flower, while Canopy bought MTL Cannabis. Tilray is diversifying into alcohol and CBD. Investors should consider risks of consolidation strategies.

aol.com3 min
AUG 23
$TLRYMed

Tilray Posted Record Fiscal 2026 Revenue -- Why Isn't the Stock Rallying?

Tilray Brands reported record fiscal 2026 revenue of $915 million, up 11%, and adjusted EBITDA of $61.1 million, also up 11%. Adjusted net income nearly doubled to $12.2 million, but missed analyst estimates. GAAP net loss was $49.6 million. Management expects fiscal 2027 adjusted EBITDA of $68M-$75M. Cannabis sales represent 29% of total revenue.

yahoo.com3 min